Chiron Real Estate Inc. Common Stock (NYSE: XRN) Stock Analysis & Fundamentals

XRNChiron Real Estate Inc. Common Stock

NYSE · US · Real Estate · REIT - Healthcare Facilities · chironre.com

37.40USD+1.42%Mkt Cap: 533.88M $P/E: 9.91Today

Chiron Real Estate Inc. is a real estate investment trust focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Chiron Real Estate In…

Industry Peers

REIT - Healthcare Facilities

Omega Healthcare Investors, Inc.

$14.80BUSDP/E 16.7

DOC

Healthpeak Properties, Inc.

Healthcare Realty Trust Incorporated

Sabra Health Care REIT, Inc.

$5.25BUSDP/E 79.0

CSH-UN

Chartwell Retirement Residences

$5.06BUSDP/E 1054.0

NHI

National Health Investors, Inc.

$3.64BUSDP/E 21.4

PHP

Primary Health Properties PLC

$3.17BUSDP/E 15.9

MPT

Medical Properties Trust Inc. common stock

Diversified Healthcare Trust

$1.96BUSD

SILA

Sila Realty Trust Inc. Common Stock

$1.68BUSDP/E 44.6

STRW

Strawberry Fields REIT Inc. Common Stock

$769.23MUSDP/E 20.9

NHP

National Healthcare Properties Inc. Class A Common Stock

Universal Health Realty Income Trust

$571.24MUSDP/E 29.6

CHCT

Community Healthcare Trust Incorporated

$422.58MUSDP/E 22.1

Key Statistics

Company

Market Cap533.88M $

Enterprise Value1.36B $

Revenue (TTM)153.35M $

Gross Profit115.06M $

Net Income (TTM)-5.84M $

Revenue/Share11.52 USD

Last Price37.40 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees30

CountryUS

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISIN—

Valuation

P/E (Trailing)9.91

P/E (Forward)-15.21

PEG5.09

EV/EBITDA14.73

EV/Revenue8.88

P/S3.50

P/B1.30

EPS (TTM)3.74

EPS (Forward)-2.44

52W Range

29.0577% of range39.93

52W High39.93 USD

52W Low29.05 USD

Profitability

Gross Margin77.91%

Oper. Margin23.17%

EBITDA Margin60.32%

Profit Margin-3.95%

ROE-1.14%

ROA-0.47%

Growth

Revenue Growth4.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF73.61M $

CapEx (TTM)81.69M $

FCF Margin61.95%

FCF Yield17.79%

Net Debt624.95M $

Net Debt/EBITDA6.76

Balance Sheet

Debt/Equity1.31

Current Ratio1.26

Quick Ratio0.95

Book Value/Sh28.42 USD

Cash/Share1.628 USD

Dividends

Fwd Div Rate1.920 USD

Trail. Div Rate2.280 USD

Div. Yield5.21%

5Y Avg Yield10.17%

Payout Ratio145.43%

Ex-Div DateSep 21, 2026

Pay DateDec 18, 2026

Splits

Last Split1:5

Split DateSep 22, 2025

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)38.00 USD

Upside (mean)+1.6%

Target Range9.000 USD – 46.00 USD

$9.000+1.6% to mean$46.00

# Analysts8

Ownership

Shares Out.13.24M

Float12.23M

Insiders6.48%

Institutions78.11%

Short Interest

Short Ratio11.5d

Short % Float6.61%

Short % Out.6.24%

Shares Short825.47K

Short (prev mo.)804.18K

Technical

SMA 5036.59 (+2.2%)

SMA 20035.10 (+6.5%)

Beta1.13

S&P 52W Chg18.16%

Avg Vol (30d)72.86K

Avg Vol (10d)113.38K

Technical Indicators

RSI (14)53.8

MACD-0.0552

MACD Signal-0.1730

MACD Hist.+0.1178

BB Upper38.04 USD

BB Middle36.30 USD

BB Lower34.55 USD

BB Width9.61%

ATR (14)1.041 USD

Vol Ratio (20d)0.97x